Persistent Posttreatment Fatigue in Thyroid Cancer Survivors A Scoping Review

被引：18

作者：

Sawka, Anna M. ^{[1
,2
]}

Naeem, Asima ^{[1
]}

Jones, Jennifer ^{[3
,4
]}

Lowe, Julia ^{[2
,5
]}

Segal, Philip ^{[1
,2
,6
]}

Goguen, Jeannette ^{[2
,7
]}

Gilbert, Jeremy ^{[2
,5
]}

Zahedi, Afshan ^{[2
,6
,8
]}

Kelly, Catherine ^{[2
,8
]}

Ezzat, Shereen ^{[9
]}

机构：

[1] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON M5G 2C4, Canada

[2] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON M5G 2C4, Canada

[3] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada

[4] Univ Hlth Network, Princess Margaret Hosp, Canc Survivorship Program, Toronto, ON M5G 2C4, Canada

[5] Sunnybrook Hlth Sci Ctr, Dept Med, Div Endocrinol, Toronto, ON M4N 3M5, Canada

[6] Mt Sinai Hosp, Dept Med, Div Endocrinol, Toronto, ON M5G 1X5, Canada

[7] St Michaels Hosp, Dept Med, Div Endocrinol, Toronto, ON M5C 2T2, Canada

[8] Womens Coll Hosp, Dept Med, Div Endocrinol, Toronto, ON M5S 1B2, Canada

[9] Univ Hlth Network, Princess Margaret Hosp, Endocrine Oncol Site Grp, Toronto, ON M5G 2C4, Canada

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2014年 / 43卷 / 02期

关键词：

Thyroid cancer; Fatigue; Vitality; Quality of life; Survivorship; QUALITY-OF-LIFE; RECOMBINANT HUMAN THYROTROPIN; PSYCHOMETRIC QUALITIES; SPANISH VERSION; CHINESE SF-36; HEALTH-STATUS; VALIDATION; INSTRUMENT; WITHDRAWAL; PROFILES;

D O I：

10.1016/j.ecl.2014.02.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The relevance of persistent posttreatment fatigue (PPF) to thyroid cancer (TO) survivor populations is not known. This article presents a scoping review, which is an overview of published research activity. Uncontrolled data suggest that PPF is one of the most common complaints in TO survivors. Furthermore, statistically significantly worse levels of fatigue were reported in TO survivors, compared with the general population or healthy controls. There was some inconsistency among PPF risk factors. More research is needed on PPF in TO survivors, including long-term prospective cohort studies, research on fatigue severity prevalence, and randomized controlled trials of treatment strategies.

引用

页码：475 / +

页数：21

共 100 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2]

Alonso J, 1998, MED CLIN-BARCELONA, V111, P410

[3] SPANISH VERSION OF THE NOTTINGHAM HEALTH PROFILE - TRANSLATION AND PRELIMINARY VALIDITY [J].

ALONSO, J ;

ANTO, JM ;

MORENO, C .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1990, 80 (06) :704-708

[4] THE SPANISH VERSION OF THE NOTTINGHAM HEALTH PROFILE - A REVIEW OF ADAPTATION AND INSTRUMENT CHARACTERISTICS [J].

ALONSO, J ;

PRIETO, L ;

ANTO, JM .

QUALITY OF LIFE RESEARCH, 1994, 3 (06) :385-393

[5]

Altman D, 2000, STAT CONFIDENCE, P116

[6]

[Anonymous], J NURS RES

[7]

[Anonymous], 2000, ONCOLOGIST, DOI DOI 10.1634/THEONCOLOGIST.5-SUPPL_2-9

[8]

[Anonymous], EITS POMS MANUAL PRO

[9]

[Anonymous], 2013 CAN CANC STAT 2

[10]

[Anonymous], 1992, POMS MANUAL PROFILE

← 1 2 3 4 5 6 7 8 9 10 →